LENZ Therapeutics, Inc.

LENZ

—

Advanced chart & tools →

LENZ Therapeutics, Inc.LENZ

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.85

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$19.09M

Net income

$-82.13M

Net margin

-430.3%

Gross margin

—

Dividends & financials

LENZ Therapeutics, Inc. (LENZ) reported revenue of $19.09M and net income of $-82.13M, or $-2.85 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.